Stille AB (OSTO:STIL) EPS without NRI: kr7.56 (TTM As of Mar. 2026)


OSTO:STIL Stille AB OSTO:STIL
98 GF Score
Price kr254.00
GF Value kr237.02
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Stille AB EPS without NRI?

Stille AB OSTO:STIL -1.93% 98 EPS without NRI is kr7.56 as of Mar. 2026. GuruFocus rates OSTO:STIL with a GF Score™ of 98/100 and a GF Value™ of kr237.02 (Fairly Valued). The stock has 4 warning signs investors should review. Among 664 Medical Devices & Instruments companies, Stille AB ranks worse than 50.9% on this metric.

Stille AB's earnings per share without non-recurring items for the three months ended in Mar. 2026 was kr2.33. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was kr7.56.

During the past 12 months, Stille AB's average earnings per share (NRI) Growth Rate was -22.50% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 7.50% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 33.00% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 11.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Stille AB's EPS without NRI or its related term are showing as below:

OSTO:STIL' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -17.3   Med: 13.35   Max: 91.5
Current: 7.5

During the past 13 years, Stille AB's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 91.50% per year. The lowest was -17.30% per year. And the median was 13.35% per year.

OSTO:STIL's 3-Year EPS without NRI Growth Rate is ranked worse than
50.9% of 664 companies
in the Medical Devices & Instruments industry
Industry Median: 8.15 vs OSTO:STIL: 7.50

Stille AB's EPS (Diluted) for the three months ended in Mar. 2026 was kr2.33. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was kr6.91.

Stille AB's EPS (Basic) for the three months ended in Mar. 2026 was kr2.33. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was kr6.91.


Stille AB  (OSTO:STIL) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Stille AB EPS without NRI Related Terms


Stille AB EPS without NRI Historical Data

* Premium members only.

The historical data trend for Stille AB's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stille AB EPS without NRI Chart

Stille AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.76 5.46 5.31 10.65 6.78

Stille AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.63 1.11 0.75 3.37 2.33

OSTO:STIL vs ISRG, BDX, MDLN: EPS without NRI Comparison

For the Medical Instruments & Supplies subindustry, Stille AB's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stille AB PE Ratio without NRI vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stille AB's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Stille AB's PE Ratio without NRI falls into.


OSTO:STIL
98GF Score
Stille AB OSTO:STIL
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stille AB EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr7.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of kr7.56 mean?
Stille AB (OSTO:STIL) has a EPS without NRI of kr7.56 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Stille AB and its competitors. According to the industry distribution chart, Stille AB ranks #338 out of 664 companies in the Medical Devices & Instruments industry, placing it in the top 50.9%.
Is Stille AB's EPS without NRI too high?
Stille AB's current EPS without NRI is kr7.56. Based on the distribution chart, Stille AB ranks #338 out of 664 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Stille AB has a GF Score™ of 98/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Stille AB's EPS without NRI compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Stille AB ranks #338 out of 664 companies for EPS without NRI. This places Stille AB in the lower half of its industry. The industry median EPS without NRI is 8.15. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Devices & Instruments company?
The median EPS without NRI among Medical Devices & Instruments companies is 8.15, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Stille AB and its competitors. For the Medical Devices & Instruments industry, the median EPS without NRI is 8.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Stille AB's current EPS without NRI is kr7.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stille AB stock overvalued right now?
Based on GuruFocus' analysis, Stille AB (OSTO:STIL) is currently considered Fairly Valued. The stock's GF Value™ is kr237.02, compared to a current price of kr254.00 — trading 7.2% above its estimated fair value. The current EPS without NRI is kr7.56. Stille AB's overall GF Score™ is 98/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Stille AB (OSTO:STIL), the current EPS without NRI is kr7.56 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stille AB (OSTO:STIL) Overvalued in 2026?

Based on GuruFocus' analysis, Stille AB stock appears to be overvalued. The current stock price of kr254.00 is trading 7.2% above its estimated GF Value™ of kr237.02. GuruFocus considers Stille AB to be Fairly Valued.

Key valuation signals for OSTO:STIL:

  • EPS without NRI: kr7.56
  • GF Value™: kr237.02 vs. price of kr254.00 (7.2% above fair value)
  • GF Score™: 98/100 with 4 warning signs

No single metric tells the full story. See the OSTO:STIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Stille AB Business Description

Other Exchanges 8R6:Germany
Address Ekbacken 11, Torshalla, SWE, 644 30
Stille AB manufactures and distributes medical devices. Its products include surgical equipment such as Surgical Scissors, Forceps, Curettes, Raspatories, Elevators, c-arm tables and instrument care education, among others.
98GF Score

Get the complete analysis for OSTO:STIL

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr254.00
Price
kr237.02
GF Value